Surgient Awarded Three New Patents for Advanced Management and Coordination of Virtualization

Patented Technologies Form the Underpinnings of Surgient's Virtual Lab

Management Platform



Jan 23, 2008, 00:00 ET from Surgient

    AUSTIN, Texas, Jan. 23 /PRNewswire/ -- Surgient, the market leader in
 virtual labs that power solutions for software testing, training and
 evaluation, today announced that it has been awarded three new patents from
 the United States Patent and Trademark Office. Reinforcing its technical
 leadership in the virtual lab management market, the three new patents
 cover technologies that enable Surgient customers to better allocate,
 manage and organize virtualized resources used to accelerate the software
 development and delivery lifecycle.
 
     The three patented technologies are key components of the Surgient
 virtual lab management platform, providing organizations with enhanced
 efficiency for all software delivery processes. Specifically, the patented
 technologies help organizations better manage and coordinate the use of
 virtual labs across both their physical and virtual infrastructures,
 ensuring that IT resources are utilized to their fullest capacity.
 
     "Since pioneering the virtual lab management market five years ago,
 Surgient has remained dedicated to growing its technical leadership
 position and developing new technologies that provide greater customer
 value," said Tim Lucas, president and CEO, Surgient. "The patented
 technologies act as the underpinnings of a number of our virtual lab
 management capabilities, helping Surgient customers better manage their
 virtual labs to ensure greater productivity gains across the application
 lifecycle. We are very proud of our software development team and their
 continued ability to deliver unique technologies that provide tremendous
 value to our customers."
 
     The three patents were awarded during the past year. The technologies
 covered by the patents were developed entirely by Surgient's research and
 development team. The patents include:
 
 
-- US Patent #6,990,666; "Near Online Server"-Describes a method for providing fractional burst capacity in delivering virtual computing resources from a centralized, shared server resource pool. -- US Patent #7,257,584; "Server File Management"-Describes a method for providing portability of virtual server "snapshots" across physical server hosts. One of the underpinnings of Surgient's library management server, this patented technology provides greater flexibility when developing, managing and deploying virtual machine images. -- US Patent #7,287,186; "Shared Nothing Virtual Cluster"-Describes a method for organizing virtual machine resources for rapid recovery, such as that required by advanced disaster recovery, reduced power consumption or business continuity scenarios. Enables virtual machines to dynamically move across physical hosts without requiring data to be moved or copied. These patents, along with previously granted Surgient patents, reinforce the uniqueness of Surgient's virtual lab management platform and associated applications, and its ability to deliver advanced manageability, scalability and flexibility in the use of virtualization in the enterprise IT environment. About Surgient Surgient is the market leader in providing virtual lab management software that powers software testing, training and evaluation. Surgient's platform and solutions automate the deployment, configuration and teardown of complex enterprise software environments. More than 1,000,000 applications have been delivered to-date through Surgient-powered virtual labs, enabling companies such as BMC, CA, Dell, EMC, GE Healthcare, HP, IBM, Merck, Microsoft, SAP and Target Corporation to dramatically accelerate software delivery, reduce operating costs, increase productivity and enable IT to better align with business priorities. Surgient partners with leading technology companies including VMware, Microsoft, HP, Platespin, Saba and Cisco/WebEx. Surgient is a private, venture-backed company based in Austin, Texas. For more information visit www.surgient.com.
Contacts: Keith Giannini Schwartz Communications 781-684-0770 surgient@schwartz-pr.com

SOURCE Surgient
    AUSTIN, Texas, Jan. 23 /PRNewswire/ -- Surgient, the market leader in
 virtual labs that power solutions for software testing, training and
 evaluation, today announced that it has been awarded three new patents from
 the United States Patent and Trademark Office. Reinforcing its technical
 leadership in the virtual lab management market, the three new patents
 cover technologies that enable Surgient customers to better allocate,
 manage and organize virtualized resources used to accelerate the software
 development and delivery lifecycle.
 
     The three patented technologies are key components of the Surgient
 virtual lab management platform, providing organizations with enhanced
 efficiency for all software delivery processes. Specifically, the patented
 technologies help organizations better manage and coordinate the use of
 virtual labs across both their physical and virtual infrastructures,
 ensuring that IT resources are utilized to their fullest capacity.
 
     "Since pioneering the virtual lab management market five years ago,
 Surgient has remained dedicated to growing its technical leadership
 position and developing new technologies that provide greater customer
 value," said Tim Lucas, president and CEO, Surgient. "The patented
 technologies act as the underpinnings of a number of our virtual lab
 management capabilities, helping Surgient customers better manage their
 virtual labs to ensure greater productivity gains across the application
 lifecycle. We are very proud of our software development team and their
 continued ability to deliver unique technologies that provide tremendous
 value to our customers."
 
     The three patents were awarded during the past year. The technologies
 covered by the patents were developed entirely by Surgient's research and
 development team. The patents include:
 
 
-- US Patent #6,990,666; "Near Online Server"-Describes a method for providing fractional burst capacity in delivering virtual computing resources from a centralized, shared server resource pool. -- US Patent #7,257,584; "Server File Management"-Describes a method for providing portability of virtual server "snapshots" across physical server hosts. One of the underpinnings of Surgient's library management server, this patented technology provides greater flexibility when developing, managing and deploying virtual machine images. -- US Patent #7,287,186; "Shared Nothing Virtual Cluster"-Describes a method for organizing virtual machine resources for rapid recovery, such as that required by advanced disaster recovery, reduced power consumption or business continuity scenarios. Enables virtual machines to dynamically move across physical hosts without requiring data to be moved or copied. These patents, along with previously granted Surgient patents, reinforce the uniqueness of Surgient's virtual lab management platform and associated applications, and its ability to deliver advanced manageability, scalability and flexibility in the use of virtualization in the enterprise IT environment. About Surgient Surgient is the market leader in providing virtual lab management software that powers software testing, training and evaluation. Surgient's platform and solutions automate the deployment, configuration and teardown of complex enterprise software environments. More than 1,000,000 applications have been delivered to-date through Surgient-powered virtual labs, enabling companies such as BMC, CA, Dell, EMC, GE Healthcare, HP, IBM, Merck, Microsoft, SAP and Target Corporation to dramatically accelerate software delivery, reduce operating costs, increase productivity and enable IT to better align with business priorities. Surgient partners with leading technology companies including VMware, Microsoft, HP, Platespin, Saba and Cisco/WebEx. Surgient is a private, venture-backed company based in Austin, Texas. For more information visit www.surgient.com.
Contacts: Keith Giannini Schwartz Communications 781-684-0770 surgient@schwartz-pr.com SOURCE Surgient